NEO6860: A Phase I, Double-Blind, Placebo-Controlled, Single and Multiple Oral Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study in Healthy Male and Female Subjects
Phase of Trial: Phase I
Latest Information Update: 20 Sep 2017
At a glance
- Drugs NEO 6860 (Primary)
- Indications Musculoskeletal pain; Neuropathic pain; Osteoarthritis; Visceral pain
- Focus Adverse reactions; First in man
- 20 Sep 2017 According to a NEOMED Institute media release, results from this trial will be presented at the Pain & Migraine Therapeutic Summit.
- 07 Feb 2017 Results published in the Journal of Pain : official journal of the American Pain Society.
- 14 May 2016 Results presented at the 35th Annual Scientific Meeting of the American Pain Society.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History